As part of the Ophthalmology Star Awards (OSA), articles by ophthalmologists published in English since January 2019 are being evaluated by an international jury. Ophthalmologists can apply for the contest until July 15, 2020, from the OSA page (https://www.vsybiotechnology.com/...) on the VSY Biotechnology website. The names of the finalists will be announced at the VSY Biotechnology Satellite Symposium during the ESCRS 2020 Congress.
Ophthalmology Star Awards will be held in memory of Chinese ophthalmologist Dr. Li Wenliang and in the name of all healthcare professionals fighting fearlessly against coronavirus. Dr. Wenliang realized the potential for a new virus outbreak in the hospital where he worked in the Wuhan District of China and continued to warn his colleagues about the contagiousness of the disease, without giving in to the pressure to stay quiet by public institutions. Despite his heroic efforts, Dr. Wenliang passed away at the age of 34 from COVID-19.
FATİH ERGİN, VSY BIOTECHNOLOGY CEO:
“WE AIM TO CONTRIBUTE TO THE DEVELOPMENT OF OPHTHALMOLOGY”
Dr. Fatih Ergin, VSY Biotechnology CEO, made a statement on the subject: “At VSY Biotechnology, we aim to contribute to the development and growth of ophthalmology. We have added the OSA Awards to our activities, and we will continue to hold them annually. In OSA 2020, we continue to include articles from respected scientists and plan to continue to support OSA research for the next several years.”
You can apply for the Ophthalmology Star Awards to participate in the competition and learn more details on the VSY Biotechnology website: https://www.vsybiotechnology.com/starawards/
Ophthalmology Star Awards will be held in memory of Chinese ophthalmologist Dr. Li Wenliang and in the name of all healthcare professionals fighting fearlessly against coronavirus. Dr. Wenliang realized the potential for a new virus outbreak in the hospital where he worked in the Wuhan District of China and continued to warn his colleagues about the contagiousness of the disease, without giving in to the pressure to stay quiet by public institutions. Despite his heroic efforts, Dr. Wenliang passed away at the age of 34 from COVID-19.
FATİH ERGİN, VSY BIOTECHNOLOGY CEO:
“WE AIM TO CONTRIBUTE TO THE DEVELOPMENT OF OPHTHALMOLOGY”
Dr. Fatih Ergin, VSY Biotechnology CEO, made a statement on the subject: “At VSY Biotechnology, we aim to contribute to the development and growth of ophthalmology. We have added the OSA Awards to our activities, and we will continue to hold them annually. In OSA 2020, we continue to include articles from respected scientists and plan to continue to support OSA research for the next several years.”
You can apply for the Ophthalmology Star Awards to participate in the competition and learn more details on the VSY Biotechnology website: https://www.vsybiotechnology.com/starawards/
